- New studies support flexible dosing and co-administration with flu vaccine
Here in the media centre you will find a range of resources including our latest and archived press releases, information on our social media policy, and our photo and video library.
These press releases are intended for business journalists & analysts/investors.
Today we have announced that our major three-part transaction with Novartis has completed.
What we do
We are a science-led global healthcare company that researches and develops a broad range of innovative products.